MedTrace Logo

Implications for Treatment of the Metabolic Syndrome

NCT00666029 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-01-23

Study results available
· View outcomes & findings →

Summary

To characterize features of metabolic syndrome in volunteers. To undertake a randomised trial to determine whether treatment with a statin improves muscle microvascular blood flow.

Conditions

  • Metabolic Syndrome

Interventions

DRUG

atorvastatin

40 m.g. o.d. tablets for 6 months

DRUG

placebo

Placebo

Sponsors & Collaborators

  • University Hospital Southampton NHS Foundation Trust

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2008-02-29
Completion
2008-02-29

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00666029 on ClinicalTrials.gov